Emil R Bulatov (Emil Bulatov)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 25

Top Venues

Biomedicines

Cancers

Life (Basel, Switzerland)

Antibodies (Basel, Switzerland)

Kazan Federal University

University of Cambridge (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Kazan Federal University

Russia

Group Leader/Researcher :: Institute of Fundamental Medicine and Biology

Education History

University of Cambridge

United Kingdom

PHD :: Chemistry

Publications

Vitaly Chasov, Irina Ganeeva, Ekaterina Zmievskaya, Damir Davletshin, Elvina Gilyazova, Aygul Valiullina, Emil R Bulatov
Cell-Based Therapy and Genome Editing as Emerging Therapeutic Approaches to Treat Rheumatoid Arthritis. Cells 13 (15) (2024)
Ekaterina A Zmievskaya, Sabir A Mukhametshin, Irina A Ganeeva, Elvina M Gilyazova, Elvira T Siraeva, Marianna P Kutyreva, Artur A Khannanov, Youyong Yuan, Emil R Bulatov
Artificial Extracellular Vesicles Generated from T Cells Using Different Induction Techniques. Biomedicines 12 (4) (2024)
Vitaly Chasov, Ekaterina Zmievskaya, Irina Ganeeva, Elvina Gilyazova, Damir Davletshin, Marat Khaliulin, Emmanuel Kabwe, Yuriy N Davidyuk, Aygul Valiullina, Albert Anatolyevich Rizvanov, Emil R Bulatov
Immunotherapy Strategy for Systemic Autoimmune Diseases: Betting on CAR-T Cells and Antibodies. Antibodies (Basel, Switzerland) 13 (1) (2024)
Ekaterina A Zmievskaya, Sabir A Mukhametshin, Irina A Ganeeva, Elvina M Gilyazova, Elvira T Siraeva, Marianna P Kutyreva, Artur A Khannanov, Youyong Yuan, Emil R Bulatov
Artificial Extracellular Vesicles Generated from T Cells Using Different Induction Techniques. Biomedicines 12 (4) (2024)
Vitaly Chasov, Irina Ganeeva, Ekaterina Zmievskaya, Damir Davletshin, Elvina Gilyazova, Aygul Valiullina, Emil R Bulatov
Cell-Based Therapy and Genome Editing as Emerging Therapeutic Approaches to Treat Rheumatoid Arthritis. Cells 13 (15) (2024)
Vitaly Chasov, Ekaterina Zmievskaya, Irina Ganeeva, Elvina Gilyazova, Damir Davletshin, Marat Khaliulin, Emmanuel Kabwe, Yuriy N Davidyuk, Aygul Valiullina, Albert Anatolyevich Rizvanov, Emil R Bulatov
Immunotherapy Strategy for Systemic Autoimmune Diseases: Betting on CAR-T Cells and Antibodies. Antibodies (Basel, Switzerland) 13 (1) (2024)
Aigul Kh Valiullina, Ekaterina A Zmievskaya, Irina A Ganeeva, Margarita N Zhuravleva, Ekaterina E Garanina, Albert Anatolyevich Rizvanov, Alexey V Petukhov, Emil R Bulatov
Evaluation of CAR-T Cells' Cytotoxicity against Modified Solid Tumor Cell Lines. Biomedicines 11 (2) (2023)
Aigul Kh Valiullina, Ekaterina A Zmievskaya, Irina A Ganeeva, Margarita N Zhuravleva, Ekaterina E Garanina, Albert Anatolyevich Rizvanov, Alexey V Petukhov, Emil R Bulatov
Evaluation of CAR-T Cells' Cytotoxicity against Modified Solid Tumor Cell Lines. Biomedicines 11 (2) (2023)
Aigul Kh Valiullina, Ekaterina A Zmievskaya, Irina A Ganeeva, Margarita N Zhuravleva, Ekaterina E Garanina, Albert Anatolyevich Rizvanov, Alexey V Petukhov, Emil R Bulatov
Evaluation of CAR-T Cells' Cytotoxicity against Modified Solid Tumor Cell Lines. Biomedicines 11 (2) (2023)
Vildan Sultanaev, Luidmila S Yakimova, Anastasia Nazarova, Olga Mostovaya, Igor A Sedov, Damir Davletshin, Elvina Gilyazova, Emil R Bulatov, Zhang-Ting Li, Dan-Wei Zhang, Ivan I Stoikov
Decasubstituted Pillar[5]arene Derivatives Containing L -Tryptophan and L -Phenylalanine Residues: Non-Covalent Binding and Release of Fluorescein from Nanoparticles. International journal of molecular sciences 24 (9) (2023)
Vildan Sultanaev, Luidmila S Yakimova, Anastasia Nazarova, Olga Mostovaya, Igor A Sedov, Damir Davletshin, Elvina Gilyazova, Emil R Bulatov, Zhang-Ting Li, Dan-Wei Zhang, Ivan I Stoikov
Decasubstituted Pillar[5]arene Derivatives Containing L -Tryptophan and L -Phenylalanine Residues: Non-Covalent Binding and Release of Fluorescein from Nanoparticles. International journal of molecular sciences 24 (9) (2023)
Diana A Mironova, Egor Makarov, Islamiya Bilyukova, Kevser Akyol, Elza D Sultanova, Vladimir Evtugyn, Damir Davletshin, Elvina Gilyazova, Emil R Bulatov, Vladimir A Burilov, Svetlana E Solovieva, Igor Antipin
Aggregation, Cytotoxicity and DNA Binding in a Series of Calix[4]arene Amphiphile Containing Aminotriazole Groups. Pharmaceuticals (Basel, Switzerland) 16 (5) (2023)
Irina Ganeeva, Ekaterina Zmievskaya, Aygul Valiullina, Anna Kudriaeva, Regina R Miftakhova, Alexey Rybalov, Emil R Bulatov
Recent Advances in the Development of Bioreactors for Manufacturing of Adoptive Cell Immunotherapies. Bioengineering (Basel, Switzerland) 9 (12) (2022)
Raniya Khadiullina, Regina Mirgayazova, Damir Davletshin, Elvina Khusainova, Vitaly Chasov, Emil R Bulatov
Assessment of Thermal Stability of Mutant p53 Proteins via Differential Scanning Fluorimetry. Life (Basel, Switzerland) 13 (1) (2022)
Raniya Khadiullina, Regina Mirgayazova, Damir Davletshin, Elvina Khusainova, Vitaly Chasov, Emil R Bulatov
Assessment of Thermal Stability of Mutant p53 Proteins via Differential Scanning Fluorimetry. Life (Basel, Switzerland) 13 (1) (2022)
Raniya Khadiullina, Regina Mirgayazova, Damir Davletshin, Elvina Khusainova, Vitaly Chasov, Emil R Bulatov
Assessment of Thermal Stability of Mutant p53 Proteins via Differential Scanning Fluorimetry. Life (Basel, Switzerland) 13 (1) (2022)
Georgiy Korenev, Sergey Yakukhnov, Anastasia Druk, Anastasia Golovina, Vitaly Chasov, Regina Mirgayazova, Roman A Ivanov, Emil R Bulatov
USP7 Inhibitors in Cancer Immunotherapy: Current Status and Perspective. Cancers 14 (22) (2022)
Aleksei Titov, Yaroslav Kaminskiy, Irina Ganeeva, Ekaterina Zmievskaya, Aygul Valiullina, Aygul Rakhmatullina, Alexey Petukhov, Regina Miftakhova, Albert Rizvanov, Emil R Bulatov
Knowns and Unknowns about CAR-T Cell Dysfunction. Cancers 14 (4) (2022)
Irina Ganeeva, Ekaterina Zmievskaya, Aygul Valiullina, Anna Kudriaeva, Regina R Miftakhova, Alexey Rybalov, Emil R Bulatov
Recent Advances in the Development of Bioreactors for Manufacturing of Adoptive Cell Immunotherapies. Bioengineering (Basel, Switzerland) 9 (12) (2022)
Ekaterina Zmievskaya, Aygul Valiullina, Irina Ganeeva, Alexey Petukhov, Albert Anatolyevich Rizvanov, Emil R Bulatov
Application of CAR-T Cell Therapy beyond Oncology: Autoimmune Diseases and Viral Infections. Biomedicines 9 (1) (2021)
Aleksei Titov, Aygul Valiullina, Ekaterina Zmievskaya, Ekaterina K Zaikova, Alexey Petukhov, Regina Miftakhova, Emil R Bulatov, Albert Anatolyevich Rizvanov
Advancing CAR T-Cell Therapy for Solid Tumors: Lessons Learned from Lymphoma Treatment. Cancers 12 (1) (2020)
Regina Mirgayazova, Raniya Khadiullina, Vitaly Chasov, Rimma Mingaleeva, Regina Miftakhova, Albert Anatolyevich Rizvanov, Emil R Bulatov
Therapeutic Editing of the TP53 Gene: Is CRISPR/Cas9 an Option? Genes 11 (6) (2020)
Almaz A Zagidullin, Vasili A Milyukov, Albert Anatolyevich Rizvanov, Emil R Bulatov
Novel approaches for the rational design of PROTAC linkers. Exploration of targeted anti-tumor therapy 1 (5) (2020)
Emil R Bulatov, Regina Sayarova, Rimma Mingaleeva, Regina Miftakhova, Marina Gomzikova, Yuri Ignatyev, Alexey Petukhov, Pavel Davidovich, Albert Rizvanov, Nickolai A Barlev
Isatin-Schiff base-copper (II) complex induces cell death in p53-positive tumors. Cell death discovery 4 (2018)
Aleksei Titov, Alexey Petukhov, Alena Staliarova, Dmitriy Motorin, Emil R Bulatov, Oleg Shuvalov, Surinder M Soond, Mauro Piacentini, Gerry Melino, Andrey Zaritskey, Nickolai A Barlev
The biological basis and clinical symptoms of CAR-T therapy-associated toxicites. Cell death & disease 9 (9) (2018)

Emil R Bulatov.css-eqlu8i{font-size:small;padding-left:4px;} (Emil Bulatov)

Publication Activity (10 Years)

Top Topics

Top Venues

Emil R Bulatov (Emil Bulatov)